Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Countering adipose tissue dysfunction could underlie the superiority of telmisartan in the treatment of obesity-related hypertension

Fig. 1

Telmisartan improves altered anthropometric parameters and visceral adipose tissue content in diet-induced obesity hypertension. a Body weight in control, DIO and DIO + Tel groups. b Body length in control, DIO and DIO + Tel groups. c Body mass index in control, DIO and DIO + Tel groups. d Abdominal circumference in control, DIO and DIO + Tel groups. e Visceral adipose tissue in control, DIO and DIO + Tel groups (number of rats = 10/group. P < 0.05 considered significant, * significant when compared to the control group, • significant when compared to the DIO group)

Back to article page